PFIZER INC.
UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, 20549FORM 10-K(Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31, 2020 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from toCommission file number 1-3619PFIZER INC.(Exact name of registrant as specified in its charter)Delaware13-5315170(State or other jurisdiction of incorporation or organization)( Employer Identification Number)235 East 42nd Street, New York, New York 10017(Address of principal executive offices) (zip code)(212) 733-2323(Registrant s telephone number, including area code)Securities registered pursuant to Section 12(b) of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon Stock, $.05 par valuePFENew York Stock Notes due 2022PFE22New York Stock Notes due 2027PFE27New York Stock ExchangeSecurities registered pursuant to Section 12(g) of the Act: NoneIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
IV intravenous J&J Johnson & Johnson JV joint venture King King Pharmaceuticals LLC (formerly King Pharmaceuticals, Inc.) LDL low density lipoprotein LIBOR London Interbank Offered Rate Lilly Eli Lilly & Company LOE loss of exclusivity MCO managed care organization mCRC metastatic colorectal cancer mCRPC metastatic castration-resistant prostate ...
Download PFIZER INC.
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: